Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Elgstrand Wettergren

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neuroscience Letters|October 16, 2012
Novel disease-specific promoters for use in gene therapy for Parkinson's diseaseErika Elgstrand Wettergren, Fredrik Gussing, Luis Quintino, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2015
Regulated Gene TherapyLudivine Breger, Erika Elgstrand Wettergren, Luis Quintino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 25, 2013
Functional neuroprotection and efficient regulation of GDNF using destabilizing domains in a rodent model of Parkinson's diseaseLuis Quintino, Giuseppe Manfré, Erika Elgstrand Wettergren, et al.
BMC Cancer|October 9, 2017
Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skinSilje Haukali Omland, Erika Elgstrand Wettergren, Sarah Mollerup, et al.
BMC Cancer|February 1, 2018
Correction to: Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skinSilje Haukali Omland, Erika Elgstrand Wettergren, Sarah Mollerup, et al.
Nature Communications|April 25, 2013
Visualization and genetic modification of resident brain microglia using lentiviral vectors regulated by microRNA-9Malin Åkerblom, Rohit Sachdeva, Luis Quintino, et al.
Molecular Therapy. Methods & Clinical Development|October 17, 2018
Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the BrainLuis Quintino, Angrit Namislo, Marcus Davidsson, et al.
Carbohydrate Research|September 16, 2008
Reductive openings of benzylidene acetals. Kinetic studies of borane and alane activation by Lewis acidsRichard Johnsson, Risto Cukalevski, Fanny Dragén, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neuroscience Letters|October 16, 2012
Novel disease-specific promoters for use in gene therapy for Parkinson's diseaseErika Elgstrand Wettergren, Fredrik Gussing, Luis Quintino, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2015
Regulated Gene TherapyLudivine Breger, Erika Elgstrand Wettergren, Luis Quintino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 25, 2013
Functional neuroprotection and efficient regulation of GDNF using destabilizing domains in a rodent model of Parkinson's diseaseLuis Quintino, Giuseppe Manfré, Erika Elgstrand Wettergren, et al.
BMC Cancer|October 9, 2017
Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skinSilje Haukali Omland, Erika Elgstrand Wettergren, Sarah Mollerup, et al.
BMC Cancer|February 1, 2018
Correction to: Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skinSilje Haukali Omland, Erika Elgstrand Wettergren, Sarah Mollerup, et al.
Nature Communications|April 25, 2013
Visualization and genetic modification of resident brain microglia using lentiviral vectors regulated by microRNA-9Malin Åkerblom, Rohit Sachdeva, Luis Quintino, et al.
Molecular Therapy. Methods & Clinical Development|October 17, 2018
Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the BrainLuis Quintino, Angrit Namislo, Marcus Davidsson, et al.
Carbohydrate Research|September 16, 2008
Reductive openings of benzylidene acetals. Kinetic studies of borane and alane activation by Lewis acidsRichard Johnsson, Risto Cukalevski, Fanny Dragén, et al.
Pageof 1